How would you define the success of Cerus's INTERCEPT Blood System for red blood cells?

Introduction

Defining the success of Cerus's INTERCEPT Blood System for red blood cells requires a comprehensive approach that considers multiple stakeholders and metrics. To address this product success metrics challenge effectively, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Cerus's INTERCEPT Blood System for red blood cells is a medical device designed to reduce the risk of transfusion-transmitted infections in red blood cell components. This system uses a photochemical treatment process to inactivate pathogens in donated blood, enhancing the safety of blood transfusions.

Key stakeholders include:

• Blood centers and hospitals (primary customers)
• Patients receiving blood transfusions (end-users)
• Regulatory bodies (e.g., FDA)
• Healthcare providers
• Cerus Corporation (the company)

User flow:

1. Blood collection: Donors give blood at collection centers.
2. Processing: The collected blood is processed using the INTERCEPT system.
3. Storage: Treated blood is stored until needed.
4. Transfusion: Hospitals administer the treated blood to patients.

This product aligns with Cerus's broader strategy of improving blood safety and reducing transfusion-transmitted infections. Compared to competitors, the INTERCEPT system offers a more comprehensive approach to pathogen inactivation, potentially addressing a wider range of known and emerging pathogens.

Product Lifecycle Stage: The INTERCEPT Blood System for red blood cells is in the growth stage, having received CE Mark approval in Europe but still pending FDA approval in the United States.

Hardware-specific context:

• Manufacturing considerations: Requires precision manufacturing to ensure consistent performance and safety.
• Supply chain dependencies: Relies on specialized materials and components, potentially impacting production scalability.
• Service infrastructure: Needs robust support and maintenance network to ensure proper functioning in healthcare settings.